Author: Abhay Panchal

The article discusses a new algorithm developed by researchers to aid in the diagnosis and management of Clostridioides difficile infection (C. diff). C. diff is a bacterial infection that can cause severe diarrhea and is commonly acquired in healthcare settings. The algorithm incorporates various clinical and laboratory factors to guide healthcare providers in making informed decisions regarding C. diff testing and treatment. It takes into account factors such as patient symptoms, risk factors, and test results to determine the likelihood of C. diff infection.

Read More

The article discusses a new genetic risk test that has the potential to reduce the frequency of colonoscopies in individuals at low risk for colorectal cancer. Researchers at the University of Michigan developed a genetic risk score based on a combination of 40 genetic markers associated with colorectal cancer. The study found that individuals with a low genetic risk score had a significantly lower risk of developing colorectal cancer compared to the general population. By incorporating this genetic risk test, it may be possible to identify individuals who can safely undergo less frequent colonoscopies or alternative screening methods.

Read More

The article published in JAMA discusses a research study that examines the impact of mask-wearing on COVID-19 transmission in schools. The study, conducted in Missouri, analyzed data from 169 schools during the 2020-2021 academic year. The findings revealed that schools with mask mandates had significantly lower rates of COVID-19 transmission compared to schools without such mandates. The study found that mask-wearing among students and staff was associated with a 3.5 times lower risk of COVID-19 outbreaks in schools. Furthermore, schools that implemented both mask mandates and improved ventilation had even lower transmission rates.

Read More

Dr. Rafael Grossmann gives a terrific overview of the state of the art and the emerging possibilities for AR/VR and XR (Extended Reality) at NextMed Health (http://NextMed.Health). Rafael is surgeon, educator and innovator, and was the first surgeon to bring Google Glass in to the Operating Room back in 2013. He has since helped innovate and catalyze the convergence of AR/VR/XR into the surgical environment and medical educational environment Collaborative and Extended Reality: Extending bridge the gaps in healthcare and education, through the convergence of technology and humanity.

Read More

The article discusses the American Medical Association’s (AMA) recent policy meeting where two important topics were addressed: artificial intelligence (AI) oversight and noncompete contracts for physicians. Regarding AI oversight, the AMA emphasized the need for robust regulation and oversight to ensure the responsible and ethical use of AI in healthcare. The potential benefits of AI in improving patient care were recognized, but concerns were raised about biases, data privacy, and the impact on physician-patient relationships. The AMA aims to develop guidelines to address these issues and advocate for policies that prioritize patient well-being. In terms of noncompete contracts, the AMA…

Read More

The article announces the unveiling of a new state-of-the-art facility at UC Davis Health in California. The five-story building, named the Vineyard Building, is dedicated to advancing healthcare and medical research. The Vineyard Building boasts cutting-edge features, including innovative simulation centers for medical training, advanced imaging technologies, and modernized laboratories. The facility aims to foster collaboration among healthcare professionals, researchers, and students to enhance patient care and drive medical advancements.

Read More

Dr. Iliyan D. Iliev, an associate professor of immunology in medicine in the Division of Gastroenterology and Hepatology, co-director of the Microbiome Core and a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease (IBD) at Weill Cornell Medicine, is the lead investigator on a grant to Weill Cornell Medicine from The Leona M. and Harry B. Helmsley Charitable Trust to target pathogenic fungi in patients with Crohn’s disease. Dr. Iliev teamed up with Dr. Randy Longman, current director of the Jill Roberts Center for Inflammatory Bowel Disease and an associate professor of medicine at Weill Cornell…

Read More

ActionFDA has approved Linzess (linaclotide) capsules to treat functional constipation in pediatric patients 6 to 17 years of age. Linzess is the first treatment for pediatric functional constipation. The recommended dosage in pediatric patients 6 to 17 years is 72 mcg orally once daily. Disease or ConditionFunctional constipation is a common condition experienced by children and adolescents in which patients have infrequent bowel movements with hard stools that can be difficult or painful to pass. There is no known underlying organic cause and there are typically multiple contributing factors.

Read More